{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T03:07:39Z","timestamp":1793502459549,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T00:00:00Z","timestamp":1748044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T00:00:00Z","timestamp":1748044800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004913","name":"Universit\u00e0 degli Studi di Palermo","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004913","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Stiff-person syndrome (SPS) is a rare autoimmune neurological disorder characterized by muscle rigidity and painful spasms, predominantly affecting young women. It is often associated with high titers of anti-glutamic acid decarboxylase (GAD) 65 antibodies. Current treatments for SPS include symptomatic therapies and immunomodulatory approaches, but there is a need for more effective therapies because many patients show incomplete responses and disease progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The systematic review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, with a literature search of PubMed, Web of Knowledge, Google Scholar, and Science Direct. Studies evaluating efficacy, safety, dosage, and impact on concomitant treatments of Rituximab (RTX) in SPS were selected. Data on anti-GAD titers were also analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Fourteen studies published between July 2005 and October 2022 were selected. The studies included 30 SPS patients treated with RTX. Data were heterogeneous regarding dosage, administration schedule, and patient assessment. RTX was generally well-tolerated, with rare side effects, including infusion reactions or infections. Significant clinical improvement occurred in most patients, with a small proportion achieving complete remission. Anti-GAD antibody titers decreased in some studies, with no consistent correlation with clinical outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Evidence supporting the efficacy of RTX in SPS is limited by the small sample sizes of the included studies and the variability in treatment protocols. However, RTX has shown efficacy for clinical improvement. Correlation with anti-GAD titers remains still unclear. Further randomized controlled trials are needed to confirm RTX as an established treatment for SPS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00415-025-13157-2","type":"journal-article","created":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T14:36:00Z","timestamp":1748097360000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Rituximab in stiff-person syndrome with glutamic acid decarboxylase 65 autoantibody: a systematic review"],"prefix":"10.1007","volume":"272","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8883-5701","authenticated-orcid":false,"given":"Antonia","family":"Pignolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Vinciguerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2829-523X","authenticated-orcid":false,"given":"Roberto","family":"Monastero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicasio","family":"Rini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0585-8351","authenticated-orcid":false,"given":"Angelo","family":"Torrente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5393-1007","authenticated-orcid":false,"given":"Carmela Rita","family":"Balistreri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5875-3126","authenticated-orcid":false,"given":"Filippo","family":"Brighina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9805-1655","authenticated-orcid":false,"given":"Vincenzo","family":"Di Stefano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,24]]},"reference":[{"key":"13157_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-022-01188-w","author":"MC Dalakas","year":"2022","unstructured":"Dalakas MC (2022) Stiff-person syndrome and GAD antibody-spectrum disorders GABAergic neuronal excitability immunopathogenesis and update on antibody therapies. Neurotherapeutics. https:\/\/doi.org\/10.1007\/s13311-022-01188-w","journal-title":"Neurotherapeutics"},{"key":"13157_CR2","doi-asserted-by":"crossref","unstructured":"Fekete R, Jankovic J (2024) Childhood stiff-person syndrome improved with rituximab. Case Rep Neurol [Internet]. 2012 May [cited 2024 Feb 12];4(2):92\u20136. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/22740823\/","DOI":"10.1159\/000339446"},{"issue":"3","key":"13157_CR3","first-page":"56","volume":"10","author":"MC Dalakas","year":"2023","unstructured":"Dalakas MC (2023) Therapies in stiff-person syndrome advances and future prospects based on disease pathophysiology. Neurol (R) Neuroimmunol Neuroinflamm 10(3):56","journal-title":"Neurol (R) Neuroimmunol Neuroinflamm"},{"key":"13157_CR4","doi-asserted-by":"crossref","unstructured":"Dalakas MC, Fujii M, Li M, McElroy B (2024) The clinical spectrum of anti-GAD antibody-positive patients with stiff-person syndrome. Neurology [Internet]. 2000 Nov 28 [cited 2024 Feb 13];55(10):1531\u20135. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/11094109\/","DOI":"10.1212\/WNL.55.10.1531"},{"key":"13157_CR5","doi-asserted-by":"crossref","unstructured":"Kodama S, Tokushige S ichi, Sugiyama Y, Sato K, Otsuka J, Shirota Y, et al. (2020) Rituximab improves not only back stiffness but also \u201cstiff eyes\u201d in stiff person syndrome: Implications for immune-mediated treatment. J Neurol Sci [Internet]. 2020 Jan 15 [cited 2025 Feb 16];408. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31734550\/","DOI":"10.1016\/j.jns.2019.116506"},{"key":"13157_CR6","doi-asserted-by":"crossref","unstructured":"Honnorat J, Saiz A, Giometto B, Vincent A, Brieva L, De Andres C, et al. (2001) Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients. Arch Neurol [Internet]. 2001 [cited 2024 Feb 13];58(2):225\u201330. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/11176960\/","DOI":"10.1001\/archneur.58.2.225"},{"key":"13157_CR7","doi-asserted-by":"crossref","unstructured":"Gresa-Arribas N, Ari\u00f1o H, Mart\u00ednez-Hern\u00e1ndez E, Petit-Pedrol M, Sabater L, Saiz A, et al. (2015) Antibodies to inhibitory synaptic proteins in neurological syndromes associated with glutamic acid decarboxylase autoimmunity. PLoS One [Internet]. 2015 Mar 16 [cited 2024 Feb 13];10(3). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/25774787\/","DOI":"10.1371\/journal.pone.0121364"},{"key":"13157_CR8","doi-asserted-by":"crossref","unstructured":"Dade M, Berzero G, Izquierdo C, Giry M, Benazra M, Delattre JY, et al. (2020) Neurological Syndromes Associated with Anti-GAD Antibodies. Int J Mol Sci [Internet]. 2020 May 2 [cited 2024 Feb 9];21(10). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32456344\/","DOI":"10.3390\/ijms21103701"},{"key":"13157_CR9","doi-asserted-by":"crossref","unstructured":"Hadavi S, Noyce AJ, David Leslie R, Giovannoni G. (201Stiff person ) syndrome. Pract Neurol [Internet]. 2011 Oct 1 [cited 2024 Feb 9];11(5):272\u201382. Available from: https:\/\/pn.bmj.com\/content\/11\/5\/272","DOI":"10.1136\/practneurol-2011-000071"},{"key":"13157_CR10","doi-asserted-by":"crossref","unstructured":"Tsiortou P, Alexopoulos H, Dalakas MC. (2021) GAD antibody-spectrum disorders: progress in clinical phenotypes, immunopathogenesis and therapeutic interventions. Ther Adv Neurol Disord [Internet]. 2021 [cited 2024 Feb 9];14. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33854562\/","DOI":"10.1177\/17562864211003486"},{"key":"13157_CR11","first-page":"13","volume":"5","author":"L Bai","year":"2022","unstructured":"Bai L, Ren H, Liang M, Lu Q, Lin N, Liu M et al (2022) Neurological disorders associated with glutamic acid decarboxylase 65 antibodies: clinical spectrum and prognosis of a cohort from China. Front Neurol 5:13","journal-title":"Front Neurol"},{"key":"13157_CR12","doi-asserted-by":"crossref","unstructured":"Kaufman DL, Houser CR, Tobin AJ. (1991) Two forms of the gamma-aminobutyric acid synthetic enzyme glutamate decarboxylase have distinct intraneuronal distributions and cofactor interactions. J Neurochem [Internet]. 1991 [cited 2024 Feb 14];56(2):720\u20133. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/1988566\/","DOI":"10.1111\/j.1471-4159.1991.tb08211.x"},{"key":"13157_CR13","unstructured":"Bhatti AB, Gazali ZA. (2015) Recent Advances and Review on Treatment of Stiff Person Syndrome in Adults and Pediatric Patients. Cureus [Internet]. 2015 Dec 22 [cited 2024 Feb 23];7(12):e427. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26848416"},{"issue":"2","key":"13157_CR14","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s11940-009-0013-9","volume":"11","author":"MC Dalakas","year":"2009","unstructured":"Dalakas MC (2009) Stiff person syndrome: advances in pathogenesis and therapeutic interventions. Curr Treat Options Neurol 11(2):102\u2013110","journal-title":"Curr Treat Options Neurol"},{"key":"13157_CR15","doi-asserted-by":"crossref","unstructured":"Dalakas MC, Fujii M, Li M, Lutfi B, Kyhos J, McElroy B. (2001) High-dose intravenous immune globulin for stiff-person syndrome. N Engl J Med [Internet]. 2001 Dec 27 [cited 2024 Feb 23];345(26):1870\u20136. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/11756577\/","DOI":"10.1056\/NEJMoa01167"},{"issue":"11","key":"13157_CR16","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.nmd.2020.09.024","volume":"30","author":"E Fileccia","year":"2020","unstructured":"Fileccia E, Rinaldi R, Minicuci GM, D\u2019Angelo R, Bartolomei L, Liguori R et al (2020) Subcutaneous immunoglobulin for maintenance therapy in stiff-person syndrome: one-year follow-up in two patients. Neuromuscul Disord 30(11):921\u2013924","journal-title":"Neuromuscul Disord"},{"issue":"6","key":"13157_CR17","doi-asserted-by":"publisher","first-page":"E817","DOI":"10.1212\/WNL.0000000000011338","volume":"96","author":"RK Burt","year":"2021","unstructured":"Burt RK, Balabanov R, Han X, Quigley K, Arnautovic I, Helenowski I et al (2021) Autologous hematopoietic stem cell transplantation for stiff-person spectrum disorder: a clinical trial. Neurology 96(6):E817\u2013E830","journal-title":"Neurology"},{"key":"13157_CR18","doi-asserted-by":"crossref","unstructured":"Pagano MB, Murinson BB, Tobian AAR, King KE. (2014) Efficacy of therapeutic plasma exchange for treatment of stiff-person syndrome. Transfusion (Paris) [Internet]. 2014 [cited 2024 Feb 23];54(7):1851\u20136. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/24527774\/","DOI":"10.1111\/trf.12573"},{"key":"13157_CR19","doi-asserted-by":"crossref","unstructured":"Di Stefano V, Alonge P, Rini N, Militello M, Lupica A, Torrente A, et al. (2024) Efgartigimod beyond myasthenia gravis: the role of FcRn-targeting therapies in stiff-person syndrome. J Neurol [Internet]. 2024 Jan 1 [cited 2024 Feb 23];271(1). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/37682316\/","DOI":"10.1007\/s00415-023-11970-1"},{"key":"13157_CR20","doi-asserted-by":"crossref","unstructured":"Silverman GJ, Weisman S. (2003) Rituximab therapy and autoimmune disorders: prospects for anti-B cell therapy. Arthritis Rheum [Internet]. 2003 Jun 1 [cited 2024 Feb 22];48(6):1484\u201392. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/12794814\/","DOI":"10.1002\/art.10947"},{"key":"13157_CR21","doi-asserted-by":"crossref","unstructured":"Selenko N, Majdic O, Draxler S, Berer A, J\u00e4ger U, Knapp W, et al. (2001) CD20 antibody (C2B8)-induced apoptosis of lymphoma cells promotes phagocytosis by dendritic cells and cross-priming of CD8+ cytotoxic T cells. Leukemia [Internet]. 2001 [cited 2024 Feb 14];15(10):1619\u201326. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/11587221\/","DOI":"10.1038\/sj.leu.2402226"},{"issue":"5","key":"13157_CR22","doi-asserted-by":"publisher","first-page":"e10838","DOI":"10.1371\/journal.pone.0010838","volume":"5","author":"M Rizzi","year":"2010","unstructured":"Rizzi M, Knoth R, Hampe CS, Lorenz P, Gougeon ML, Lemercier B et al (2010) Long-lived plasma cells and memory b cells produce pathogenic anti-GAD65 autoantibodies in stiff person syndrome. PLoS One 5(5):e10838","journal-title":"PLoS One"},{"key":"13157_CR23","doi-asserted-by":"crossref","unstructured":"Baker MR, Das M, Isaacs J, Fawcett PRW, Bates D. (2005) Treatment of stiff person syndrome with rituximab. J Neurol Neurosurg Psychiatry [Internet]. 2005 Jul [cited 2024 Feb 12];76(7):999\u20131001. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/15965211\/","DOI":"10.1136\/jnnp.2004.051144"},{"key":"13157_CR24","doi-asserted-by":"crossref","unstructured":"Lobo ME, Ara\u00fajo MLB, Tomaz CAB, Allam N. (2010) Stiff-person syndrome treated with rituximab. BMJ Case Rep [Internet]. 2010 Dec 13 [cited 2024 Feb 12];2010. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/22802263\/","DOI":"10.1136\/bcr.05.2010.3021"},{"issue":"3","key":"13157_CR25","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.jocn.2009.06.015","volume":"17","author":"JL Dupond","year":"2010","unstructured":"Dupond JL, Essalmi L, Gil H, Meaux-Ruault N, Hafsaoui C (2010) Rituximab treatment of stiff-person syndrome in a patient with thymoma, diabetes mellitus and autoimmune thyroiditis. J Clin Neurosci 17(3):389\u2013391","journal-title":"J Clin Neurosci"},{"issue":"5","key":"13157_CR26","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/RHU.0b013e3181e931fa","volume":"16","author":"EA Bacorro","year":"2010","unstructured":"Bacorro EA, Tehrani R (2010) Stiff-person syndrome: persistent elevation of glutamic acid decarboxylase antibodies despite successful treatment with rituximab. J Clin Rheumatol 16(5):237\u2013239","journal-title":"J Clin Rheumatol"},{"key":"13157_CR27","doi-asserted-by":"crossref","unstructured":"Katoh N, Matsuda M, Ishii W, Morita H, Ikeda SI. (2010) Successful treatment with rituximab in a patient with stiff-person syndrome complicated by dysthyroid ophthalmopathy. Intern Med [Internet]. 2010 [cited 2024 Feb 13];49(3):237\u201341. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/20118602\/","DOI":"10.2169\/internalmedicine.49.2821"},{"issue":"4","key":"13157_CR28","doi-asserted-by":"publisher","first-page":"677","DOI":"10.4158\/EP09385.RA","volume":"16","author":"S Madaschi","year":"2010","unstructured":"Madaschi S, Rossini A, Formenti I, Lampasona V, Marzoli SB, Cammarata G et al (2010) Treatment of thyroid-associated orbitopathy with rituximab\u2013a novel therapy for an old disease: case report and literature review. Endocr Pract 16(4):677\u2013685","journal-title":"Endocr Pract"},{"issue":"1","key":"13157_CR29","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s00415-011-6123-9","volume":"259","author":"A Qureshi","year":"2012","unstructured":"Qureshi A, Hennessy M (2012) Stiff person syndrome (SPS) complicated by respiratory failure: Successful treatment with rituximab. J Neurol 259(1):180\u2013181","journal-title":"J Neurol"},{"key":"13157_CR30","doi-asserted-by":"crossref","unstructured":"Sevy A, Franques J, Chiche L, Pouget J, Attarian S. (2010) [Successful treatment with rituximab in a refractory Stiff-person syndrome]. Rev Neurol (Paris) [Internet]. 2012 Apr [cited 2024 Feb 13];168(4):375\u20138. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/22340864\/","DOI":"10.1016\/j.neurol.2011.09.008"},{"key":"13157_CR31","doi-asserted-by":"crossref","unstructured":"Dalakas MC, Rakocevic G, Dambrosia JM, Alexopoulos H, McElroy B. (2017) A double-blind, placebo-controlled study of rituximab in patients with stiff person syndrome. Ann Neurol [Internet]. 2017 Aug 1 [cited 2024 Feb 12];82(2):271\u20137. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/28749549\/","DOI":"10.1002\/ana.25002"},{"issue":"9","key":"13157_CR32","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1136\/ard.2008.103721","volume":"68","author":"N Venhoff","year":"2009","unstructured":"Venhoff N, Rizzi M, Salzer U, Bossaller L, Thoden J, Eibel H et al (2009) Monozygotic twins with stiff person syndrome and autoimmune thyroiditis: rituximab inefficacy in a double-blind, randomised, placebo controlled crossover study. Ann Rheum Dis 68(9):1506\u20131508","journal-title":"Ann Rheum Dis"},{"key":"13157_CR33","doi-asserted-by":"crossref","unstructured":"Dimova P, Minkin K. (2021) Case Report: Multisystem Autoimmune and Overlapping GAD65-Antibody-Associated Neurological Disorders With Beneficial Effect of Epilepsy Surgery and Rituximab Treatment. Front Neurol [Internet]. 2021 Jan 20 [cited 2024 Mar 20];12:756668. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/35126284","DOI":"10.3389\/fneur.2021.756668"},{"key":"13157_CR34","doi-asserted-by":"publisher","DOI":"10.1177\/2058739220942340","author":"V Di Stefano","year":"2020","unstructured":"Di Stefano V, Barbone F, Ferrante C, Telese R, Vitale M, Onofrj M et al (2020) Inflammatory polyradiculoneuropathies: clinical and immunological aspects, current therapies, and future perspectives. Eur J Inflamm. https:\/\/doi.org\/10.1177\/2058739220942340","journal-title":"Eur J Inflamm"},{"issue":"24","key":"13157_CR35","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1212\/WNL.0b013e318296e92b","volume":"80","author":"JM L\u00e9ger","year":"2013","unstructured":"L\u00e9ger JM, Viala K, Nicolas G, Cr\u00e9ange A, Vallat JM, Pouget J et al (2013) Placebo-controlled trial of rituximab in IgM anti-myelin\u2013associated glycoprotein neuropathy. Neurology 80(24):2217","journal-title":"Neurology"},{"key":"13157_CR36","doi-asserted-by":"crossref","unstructured":"Dalakas MC, Yi J. (2023) Late-onset stiff-person syndrome: challenges in diagnosis and management. Ther Adv Neurol Disord [Internet]. 2023 Jan [cited 2024 Feb 22];16. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/38152088\/","DOI":"10.1177\/17562864231214315"},{"key":"13157_CR37","doi-asserted-by":"crossref","unstructured":"Yilmaz FM, Little D, Gallagher M, Colcher A. (2019) Anti-glutamate Dehydrogenase Antibody Positive Cerebellar Ataxia and Stiff Person Syndrome Responding to Dual Treatment with Steroids and Intravenous Immunoglobulin: A Case Presentation and Literature Review. Cureus [Internet]. 2019 Jun 6 [cited 2024 Feb 9];11(6). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31410334\/","DOI":"10.7759\/cureus.4851"},{"key":"13157_CR38","doi-asserted-by":"crossref","unstructured":"Gilhus NE. (2016) Myasthenia Gravis. Longo DL, editor. N Engl J Med [Internet]. 2016 Dec 29 [cited 2024 Feb 9];375(26):2570\u201381. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/28029925\/","DOI":"10.1056\/NEJMra1602678"},{"issue":"23","key":"13157_CR39","volume":"94","author":"P Zdziarski","year":"2015","unstructured":"Zdziarski P (2015) A case of stiff person syndrome: immunomodulatory effect of benzodiazepines: successful rituximab and tizanidine therapy. Medicine (United States) 94(23):e954","journal-title":"Medicine (United States)"},{"key":"13157_CR40","doi-asserted-by":"crossref","unstructured":"Horiuchi K, Maruo Y, Matsuoka S. (2018) Stiff-person Syndrome with Waldenstr\u00f6m Macroglobulinemia. Intern Med [Internet]. 2018 [cited 2025 Feb 16];57(22):3313\u20136. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29984750\/","DOI":"10.2169\/internalmedicine.1043-18"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13157-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-025-13157-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13157-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T09:24:53Z","timestamp":1749893093000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-025-13157-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,24]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["13157"],"URL":"https:\/\/doi.org\/10.1007\/s00415-025-13157-2","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,24]]},"assertion":[{"value":"9 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"417"}}